Oklahoma Center for the Advancement of Science and Technology
7
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Glucose Control In Hematopoetic Stem Cell Transplant
Role: collaborator
Neurocognitive Empowerment for Addiction Treatment (NEAT) in Opioid Use Disorder and Amphetamine Use Disorder
Role: collaborator
Holistic Assessment of Tulsa Children's Health
Role: collaborator
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
Role: collaborator
Exercise for Women With Peripheral Arterial Disease
Role: collaborator
Home-based vs. Supervised Exercise for People With Claudication
Role: collaborator
OCAST Cessation Study
Role: collaborator
All 7 trials loaded